Contraceptives - UK

Published by: Mintel International Group Ltd.

Published: Jul. 1, 2008 - 79 Pages

Table of Contents

Market in Brief

Market growth

Emergency contraception selling well

Manufacturer activity dominated by Durex

Time for a change - more segmentation

The solution to risk

Outlook

Internal Market Environment

Key points

Sexual behaviour

Women - more sexual partners

Figure 1: Number of sexual partners in the previous year, by gender, 2000/01-2006/07

Figure 2: Number of sexual partners in the previous year, by gender and age, 2006/07

Need to educate young adults

Young people, sex and alcohol

Young people’s access to contraception

Figure 3: User-dependent contraceptive methods provided by CCCs to women, by age, 2006/07

Teenage pregnancy

Drive to reduce teenage pregnancy

Association for Young People’s Health

LARCs, the pill and preventative healthcare

Increased pharmacy involvement

Moral outrage

Drive to educate about sexual health

Review of sex and relationships education in schools

Rate of STIs

Figure 4: Total new STI diagnoses at GUM clinics in UK, 2000-06

STI diagnoses rise

Lessons from the LGBT community

Intensification in lobbying for action

Broader Market Environment

Key points

Increasing affluence

Figure 5: Forecast adult population trends, by socio-economic group, 2003-13

Ageing population

Figure 6: Structure of the UK population, by age and gender, 2003-13

Divorced - a potential market

Figure 7: Birth, marriage and divorce rates, 2005-13

Competitive Context

Key points

The pill and condoms - dominant contraception methods

Figure 8: Trends in use of contraception methods in Great Britain, 2003/04-2006/07

NHS distribution v OTC

Prescription contraceptives

Figure 9: Contraceptive prescription items dispensed in the community*, 2000-06

Oral contraceptives dominate

Other methods

Vasectomy and sterilisation in decline

Figure 10: Contraceptive prescription items dispensed in the community*, 2000-05

The future of prescription-only methods in the UK

The no-prescription pill

More injections and implants

Strengths and Weaknesses in the Market

Strengths

Weaknesses

Market Value and Forecast

Key points

UK retail sales of contraceptives

Figure 11: Estimated UK retail sales of contraceptives, by value, 2003-13

Mixed fortunes for contraceptives

The future

Forecast

Factors used in the forecast

Segment Performance

Key points

Condoms

Figure 12: Estimated distribution of condoms through the NHS and retail, by volume, 2003-08

Decline in NHS

Condom sales in decline

Figure 13: Estimated UK retail sales of condoms, by volume and value, 2003-13

Causes for decline

Figure 14: Price positioning for Durex Extra Safe condoms in the UK, 2008

Trading up

Femidom fighting a losing battle in retail

The future

The morning-after pill

Figure 15: Estimated UK retail sales of the morning-after pill, by value, 2003-13

Sales increase

Use of emergency contraception

Figure 16: Use of emergency contraception during the year prior to interview, 2002/03-2006/07

Once-only use prevails

Market Share

Key points

Brand map of manufacturers and brands

Figure 17: Key manufacturers and brands in the contraceptives market, 2008

Pasante dares but Durex wins

Figure 18: Estimated manufacturer/brand shares in the UK retail condoms market, by value, 2005 and 2007

Limited potential for new entrants

Companies and Products

Key points

Company profiles

SSL International (Durex)

Ansell Consumer Healthcare (Mates)

Pasante Healthcare (Pasante, Desire)

Church & Dwight (Trojan)

Bayer Schering Pharma

Sexual Health Group Plc (Condomania)

Other smaller companies

Female Health Company (Femidom)

Condomi Health International GmbH (Condomi)

Own-label

Brand Communication and Promotion

Key points

Main monitored advertising expenditure

Figure 19: Main monitored media advertising expenditure on contraceptives, 2003-07

Limited adspend

Durex reaps rewards for big spend

Figure 20: Main monitored advertising expenditure on contraceptives, by advertiser and brand, 2003-07

Schering toys with text messaging

Investment in associated products

Press and radio - favoured media

Figure 21: Main monitored advertising expenditure on contraceptives, by media type, 2003-07

Channels to Market

Key points

Condoms

Figure 22: UK retail distribution of condoms, by outlet type, 2005 and 2007

Grocery multiples gain ground

Polarisation in pricing strategy

Internet - the private channel

The future of condom retailing

Superdrug turns pink

Emergency contraceptive pill

Figure 23: Where hormonal contraception obtained, 2002/03-2006/07

Increase in pharmacy sales

Emergency contraception and CCCs

Figure 24: Occasions on which emergency contraceptives were dispensed at community contraception clinics, by type, 2002/03-2006/07

The Consumer - Contraception Used

Key points

Protection used

Figure 25: Methods of contraception/protection currently used by self or partner, March 2008

Condoms - it’s a man’s world

Protect against STIs

Condoms - for enjoyment

The over-45s - a potential growth group

Target the young

Better communication for non-users

Regional variation

Contraception repertoire

Figure 26: Number of types of contraception used, by type of contraception currently used by self or partner, March 2008

One contraceptive method is the norm

Appendix

Advertising data

Abbreviations

Appendix: Contraception Used - Detailed Consumer Demographics

Figure 31: Methods of contraception/protection currently used by self or partner, by demographic sub-groups, March 2008

Abstract

This report looks at how trends in contraceptive methods have evolved since Mintel last looked at the market in September 2006, and in particular how the retail sector is faring.

As the nation’s sexual health deteriorates, with increasing rates of sexually transmitted infections (STIs), the stagnation in volume condom sales is a worry and Mintel looks at the various initiatives that have been launched to try to redress the situation.

Main report themes

• There is a two-pronged focus in terms of promoting contraception to prevent pregnancy and prevent STIs. The main emphasis of contraception is on pregnancy prevention: the pill is by far the most prescribed contraception method and usage is increasing. Future campaigns need a joint focus rather than dealing with them as separate issues.
• The poor performance in the condom sector highlights a weaker focus on combating the spread of STIs.
• There is increasing focus on promoting condoms towards women, the impetus being that women should look after their health. Previously emphasis has been more towards men.
• As the grocery multiples gather momentum, how can pharmacies rekindle their relevance to the contraceptives market?
• Does the dominance of the Durex brand leave room for manoeuvre for other manufacturers?
• The emergency contraceptives market (ie the morning-after pill) is growing at a fast rate as consumers favour the convenience factor in pharmacy purchasing, as opposed to from a doctor. Should doctors play a greater role in looking after patients’ sexual health and education?
• Forecast

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.